explore -WSS

explore

author：comprehensive 2025-09-30 17:29:57 - browse：9

A sign of The Cigna Group in front of trees with orange and green leaves — insurance overage from STAT — Joe Buglewicz/Bloomberg

Cigna and Humana are in discussions to merge, a potential move that would create a health insurance and prescription drug benefits titan with approximately $300 billion of annual revenue.

A proposed transaction would almost certainly prompt a close review from antitrust enforcers at the Department of Justice and the Federal Trade Commission. A merged Cigna-Humana would further consolidate the market for pharmacy benefit managers. PBMs are companies that serve as the controversial middlemen of drug pricing negotiations, and of the four largest, two are owned by Cigna and Humana.

The Wall Street Journal first reported the talks between Cigna and Humana on Wednesday, citing sources close to the situation. Wendell Potter, a health insurance whistleblower who used to work at Cigna, also wrote about merger discussions between Cigna and Humana on his blog Tuesday.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Deliver public health messages at the right time

WSS

Pushing for an NIH office for post

Can gargling with Listerine treat gonorrhea of the mouth?

UCLA team creates talking throat patch for voice disorders

Can gargling with Listerine treat gonorrhea of the mouth?

Readout LOUD podcast: ALS dilemma, first MASH drug, and more

Change Healthcare outage fallout shows need for new oversight

explore

explore

entertainment

After affirmative action ruling, medical educators look to 'holistic review'

Brain MRIs reveal impact of 'toxic stress' on Black children

Medical leaders decry Supreme Court decision on affirmative action

Brain MRIs reveal impact of 'toxic stress' on Black children

Bright Health sells Medicare Advantage business to Molina

Chemotherapy before breast cancer surgery might fuel metastasis

Supreme Court strikes down use of affirmative action

As health system earnings go up, health insurance stocks go down

Drug repurposing or repositioning? The language matters

AI for drug discovery: Experts on separating hype from reality

leisure time

Acadia's Nuplazid fails as schizophrenia medicine in Phase 3 study

HHS secretary Becerra pressed on Change HealthCare cyberattack

Readout Newsletter: Bristol, Sangamo, Gilead, and more

Warren pushes Witty on UnitedHealth's control over physicians

Empower primary care with adequate payments and technology

Why depression after traumatic brain injury is distinct

hotspot

explore

entertainment

knowledge